Six1: A critical transcription factor in tumorigenesis

International Journal of Cancer

Volumn 136, Issue 6, 2015, Pages 1245-1253

  Wu, Wangjun ^a   Ren, Zhuqing ^b   Li, Pinghua ^a   Yu, Debing ^a   Chen, Jie ^a   Huang, Ruihua ^a   Liu, Honglin ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cancer; Disease; Organs development; Six1

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 185; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EYA; TRANSCRIPTION FACTOR EYA1; TRANSCRIPTION FACTOR SIX1; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; SIX1 PROTEIN, HUMAN;

ADVANCED CANCER; BRANCHIOOTORENAL SYNDROME; BREAST CANCER; CARCINOGENESIS; DISTANT METASTASIS; DNA METHYLATION; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; EYE DEVELOPMENT; GENE MUTATION; GENETIC DISORDER; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; KIDNEY DEVELOPMENT; LIVER CELL CARCINOMA; LYMPHANGIOGENESIS; MUSCLE DEVELOPMENT; NEPHROBLASTOMA; NONHUMAN; OPEN ANGLE GLAUCOMA; ORGANOGENESIS; OVARY CANCER; OVERALL SURVIVAL; REGULATORY MECHANISM; RHABDOMYOSARCOMA; SENSE ORGAN; SHORT SURVEY; TUMOR RECURRENCE; UTERINE CERVIX CANCER; ANIMAL; BRANCHIO-OTO-RENAL SYNDROME; PHYSIOLOGY;

ANIMALS; BRANCHIO-OTO-RENAL SYNDROME; CARCINOGENESIS; HOMEODOMAIN PROTEINS; HUMANS; ORGANOGENESIS; TRANSCRIPTION FACTORS;

EID: 84922213591     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28755     Document Type: Short Survey

References (139)

1. Kumar JP. The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci 2009;66:565-83.
2. Kawakami K, Sato S, Ozaki H, et al. Six family genes-structure and function as transcription factors and their roles in development. Bioessays 2000;22:616-26.
3. Laclef C, Hamard G, Demignon J, et al. Altered myogenesis in Six1-deficient mice. Development 2003;130:2239-52.
4. Grifone R, Demignon J, Houbron C, et al. Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo. Development 2005;132:2235-49.
5. Richard AF, Demignon J, Sakakibara I, et al. Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression. Dev Biol 2011;359:303-20.
6. Xu PX, Zheng W, Huang L, et al. Six1 is required for the early organogenesis of mammalian kidney. Development 2003;130:3085-94.
7. Laclef C, Souil E, Demignon J, et al. Thymus, kidney and craniofacial abnormalities in Six 1 deficient mice. Mech Dev 2003;120:669-79.
8. Nie XG, Xu JS, El-Hashash A, et al. Six1 regulates Grem1 expression in the metanephric mesenchyme to initiate branching morphogenesis. Dev Biol 2011;352:141-51.
9. Zheng W, Huang L, Wei ZB, et al. The role of Six1 in mammalian auditory system development. Development 2003;130:3989-4000.
10. Ozaki H, Nakamura K, Funahashi J, et al. Six1 controls patterning of the mouse otic vesicle. Development 2004;131:551-62.
11. Bricaud O, Collazo A. The transcription factor six1 inhibits neuronal and promotes hair cell fate in the developing zebrafish (Danio rerio) inner ear. J Neurosci 2006;26:10438-51.
12. Bricaud O, Collazo A. Balancing cell numbers during organogenesis: Six1a differentially affects neurons and sensory hair cells in the inner ear. Dev Biol 2011;357:191-201.
13. Konishi Y, Ikeda K, Iwakura Y, et al. Six1 and Six4 promote survival of sensory neurons during early trigeminal gangliogenesis. Brain Res 2006;1116:93-102.
14. Bessarab DA, Chong SW, Korzh V. Expression of zebrafish six1 during sensory organ development and myogenesis. Dev Dynam 2004;230:781-6.
15. Christophorou NAD, Bailey AP, Hanson S, et al. Activation of Six1 target genes is required for sensory placode formation. Dev Biol 2009;336:327-36.
16. Anderson AM, Weasner BM, Weasner BP, et al. Dual transcriptional activities of SIX proteins define their roles in normal and ectopic eye development. Development 2012;139:991-1000.
17. Zou D, Silvius D, Fritzsch B, et al. Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes. Development 2004;131:5561-72.
18. Guo CS, Sun Y, Zhou B, et al. A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis. J Clin Invest 2011;121:1585-95.
19. Moody SA, Mhaske P, Pignoni F, et al. Identification of novel candidate Six1-interacting proteins with potential roles in cranial placode development. Dev Biol 2010;344:455-6.
20. Ford HL, Kabingu EN, Bump EA, et al. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci USA 1998;95:12608-13.
21. Reichenberger KJ, Coletta RD, Schulte AP, et al. Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res 2005;65:2668-75.
22. Coletta RD, Christensen KL, Micalizzi DS, et al. Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res 2008;68:2204-13.
23. Micalizzi DS, Wang CA, Farabaugh SM, et al. Homeoprotein Six1 Increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res 2010;70:10371-80.
24. Wang CA, Jedlicka P, Patrick AN, et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest 2012;122:1895-906.
25. Behbakht K, Qamar L, Aldridge CS, et al. Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res 2007;67:3036-42.
26. Tan J, Zhang CX, Qian JZ. Expression and significance of Six1 and Ezrin in cervical cancer tissue. Tumor Biol 2011;32:1241-7.
27. Wan F, Miao X, Quraishi I, et al. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer 2008;123:32-40.
28. Ng KT, Man K, Sun CK, et al. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer 2006;95:1050-5.
29. Ng KTP, Lee TKW, Cheng QA, et al. Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. Int J Cancer 2010;127:859-72.
30. Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004;10:175-81.
31. Sehic D, Karlsson J, Sandstedt B, et al. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor. Pediatr Blood Cancer 2012;59:62-8.
32. Ono H, Imoto I, Kozaki K, et al. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 2012;31:4923-34.
33. Buckingham M, Bajard L, Chang T, et al. The formation of skeletal muscle: from somite to limb. J Anat 2003;202:59-68.
34. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000;57:16-25.
35. Tajbakhsh S, Rocancourt D, Cossu G, et al. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 1997;89:127-38.
36. Spitz F, Demignon J, Porteu A, et al. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Proc Natl Acad Sci USA 1998;95:14220-5.
37. Giordani J, Bajard L, Demignon J, et al. Six proteins regulate the activation of Myf5 expression in embryonic mouse limbs. Proc Natl Acad Sci USA 2007;104:11310-15.
38. Zhang H, Stavnezer E. Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3. J Biol Chem 2009;284:2867-79.
39. Liu YB, Chakroun I, Yang DB, et al. Six1 Regulates MyoD expression in adult muscle progenitor cells. PLoS One 2013;8:e67762.
40. Le Grand F, Grifone R, Mourikis P, et al. Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol 2012;198:815-32.
41. Grifone R, Laclef C, Spitz F, et al. Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol Cell Biol 2004;24:6253-67.
42. Nord H, Skalman LN, von Hofsten J. Six1 regulates proliferation of Pax7-positive muscle progenitors in zebrafish. J Cell Sci 2013;126:1868-80.
43. Bailey AP, Streit A. Sensory organs: Making and breaking the pre-placodal region. Curr Top Dev Biol 2006;72:167-240.
44. Baker CVH, Bronner-Fraser M. Vertebrate cranial placodes I. Embryonic induction. Dev Biol 2001;232:1-61.
45. Schlosser G. Induction and specification of cranial placodes. Dev Biol 2006;294:303-51.
46. Brugmann SA, Pandur PD, Kenyon KL, et al. Six1 promotes a placodal fate within the lateral neurogenic ectoderm by functioning as both a transcriptional activator and repressor. Development 2004;131:5871-81.
47. Cheyette BNR, Green PJ, Martin K, et al. The Drosophila sine oculis locus encodes a homeodomain-containing protein required for the development of the entire visual-system. Neuron 1994;12:977-96.
48. Serikaku MA, Otousa JE. Sine oculis is a homeobox gene required for drosophila visual-system development. Genetics 1994;138:1137-50.
49. Pignoni F, Hu BR, Zavitz KH, et al. The eye-specification proteins so and eya form a complex and regulate multiple steps in Drosophila eye development. Cell 1997;91:881-91.
50. Bonini NM, Leiserson WM, Benzer S. The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell 1993;72:379-95.
51. Zimmerman JE, Bui QT, Liu HX, et al. Molecular genetic analysis of Drosophila eyes absent mutants reveals an eye enhancer element. Genetics 2000;154:237-46.
52. Mardon G, Solomon NM, Rubin GM. dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 1994;120:3473-86.
53. Shen W, Mardon G. Ectopic eye development in Drosophila induced by directed dachshund expression. Development 1997;124:45-52.
54. Pineda D, Gonzalez J, Callaerts P, et al. Searching for the prototypic eye genetic network: Sine oculis is essential for eye regeneration in planarians. Proc Natl Acad Sci USA 2000;97:4525-9.
55. Halder G, Callaerts P, Gehring WJ. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 1995;267:1788-92.
56. Niimi T, Seimiya M, Kloter U, et al. Direct regulatory interaction of the eyeless protein with an eye-specific enhancer in the sine oculis gene during eye induction in Drosophila. Development 1999;126:2253-60.
57. Halder G, Callaerts P, Flister S, et al. Eyeless initiates the expression of both sine oculis and eyes absent during Drosophila compound eye development. Development 1998;125:2181-91.
58. Punzo C, Seimiya M, Flister S, et al. Differential interactions of eyeless and twin of eyeless with the sine oculis enhancer. Development 2002;129:625-34.
59. Pauli T, Seimiya M, Blanco J, et al. Identification of functional sine oculis motifs in the autoregulatory element of its own gene, in the eyeless enhancer and in the signalling gene hedgehog. Development 2005;132:2771-82.
60. Ramdas WD, van Koolwijk LM, Ikram MK, et al. A genome-wide association study of optic disc parameters. PLoS Genet 2010;6:e1000978.
61. Lagutin O, Zhu CC, Furuta Y, et al. Six3 promotes the formation of ectopic optic vesicle-like structures in mouse embryos. Dev Dyn 2001;221:342-9.
62. Kobayashi M, Nishikawa K, Suzuki T, et al. The homeobox protein Six3 interacts with the Groucho corepressor and acts as a transcriptional repressor in eye and forebrain formation. Dev Biol 2001;232:315-26.
63. Oliver G, Mailhos A, Wehr R, et al. Six3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development. Development 1995;121:4045-55.
64. Loosli F, Winkler S, Wittbrodt J. Six3 overexpression initiates the formation of ectopic retina. Genes Dev 1999;13:649-54.
65. Wiggs JL, Yaspan BL, Hauser MA, et al. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet 2012;8:e1002654.
66. Ruf RG, Xu PX, Silvius D, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci USA 2004;101:8090-5.
67. Buller C, Xu X, Marquis V, et al. Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. Hum Mol Genet 2001;10:2775-81.
68. Li X, Oghi KA, Zhang J, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 2003;426:247-54.
69. Delpire E, Lu J, England R, et al. Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet 1999;22:192-5.
70. Dixon MJ, Gazzard J, Chaudhry SS, et al. Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. Hum Mol Genet 1999;8:1579-84.
71. Ando Z, Sato S, Ikeda K, et al. Slc12a2 is a direct target of two closely related homeobox proteins, Six1 and Six4. FEBS J 2005;272:3026-41.
72. Ikeda K, Ookawara S, Sato S, et al. Six1 is essential for early neurogenesis in the development of olfactory epithelium. Dev Biol 2007;311:53-68.
73. Chen B, Kim EH, Xu PX. Initiation of olfactory placode development and neurogenesis is blocked in mice lacking both Six1 and Six4. Dev Biol 2009;326:75-85.
74. Ahrens K, Schlosser G. Tissues and signals involved in the induction of placodal Six1 expression in Xenopus laevis. Dev Biol 2005;288:40-59.
75. Ikeda K, Kageyama R, Suzuki Y, et al. Six1 is indispensable for production of functional progenitor cells during olfactory epithelial development. Int J Dev Biol 2010;54:1453-64.
76. Suzuki Y, Ikeda K, Kawakami K. Expression of Six1 and Six4 in mouse taste buds. J Mol Histol 2010;41:205-14.
77. Suzuki Y, Ikeda K, Kawakami K. Regulatory role of Six1 in the development of taste papillae. Cell Tissue Res 2010;339:513-25.
78. Suzuki Y, Ikeda K, Kawakami K. Development of gustatory papillae in the absence of Six1 and Six4. J Anat 2011;219:710-21.
79. Dressler GR. The cellular basis of kidney development. Annu Rev Cell Dev Biol 2006;22:509-29.
80. Saxen L, Sariola H, Lehtonen E. Sequential Cell and Tissue Interactions Governing Organogenesis of the Kidney. Anat Embryol 1986;175:1-6.
81. Costantini F. Renal branching morphogenesis: concepts, questions, and recent advances. Differentiation 2006;74:402-21.
82. Xu PX, Adams J, Peters H, et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999;23:113-7.
83. Ohto H, Kamada S, Tago K, et al. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol 1999;19:6815-24.
84. Bouchard M, Souabni A, Mandler M, et al. Nephric lineage specification by Pax2 and Pax8. Genes Dev 2002;16:2958-70.
85. Brophy PD, Ostrom L, Lang KM, et al. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 2001;128:4747-56.
86. Torres M, GomezPardo E, Dressler GR, et al. Pax-2 controls multiple steps of urogenital development. Development 1995;121:4057-65.
87. Nishinakamura R, Matsumoto Y, Nakao K, et al. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 2001;128:3105-15.
88. Chai L, Yang JC, Di CH, et al. Transcriptional activation of the SALL1 by the human SIX1 homeodomain during kidney development. J Biol Chem 2006;281:18918-26.
89. Kobayashi H, Kawakami K, Asashima M, et al. Six1 and Six4 are essential for Gdnf expression in the metanephric mesenchyme and ureteric bud formation, while Six1 deficiency alone causes mesonephric-tubule defects. Mech Develop 2007;124:290-303.
90. Nie XG, Sun JB, Gordon RE, et al. SIX1 acts synergistically with TBX18 in mediating ureteral smooth muscle formation. Development 2010;137:755-65.
91. Fujimoto Y, Tanaka SS, Yamaguchi YL, et al. Homeoproteins Six1 and Six4 regulate male sex determination and mouse gonadal development. Dev Cell 2013;26:416-30.
92. McCoy EL, Kawakami K, Ford HL, et al. Expression of Six1 homeobox gene during development of the mouse submandibular salivary gland. Oral Dis 2009;15:407-13.
93. El-Hashash AHK, Al Alam D, Turcatel G, et al. Six1 transcription factor is critical for coordination of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung. Dev Biol 2011;353:242-58.
94. Lu K, Reddy R, Berika M, et al. Abrogation of Eya1/Six1 disrupts the saccular phase of lung morphogenesis and causes remodeling. Dev Biol 2013;382:110-23.
95. Nonomura K, Takahashi M, Wakamatsu Y, et al. Dynamic expression of Six family genes in the dental mesenchyme and the epithelial ameloblast stem/progenitor cells during murine tooth development. J Anat 2010;216:80-91.
96. Wang C, Gargollo P, Guo CS, et al. Six1 and Eya1 are critical regulators of peri-cloacal mesenchymal progenitors during genitourinary tract development. Dev Biol 2011;360:186-94.
97. Ford HL, Landesman-Bollag E, Dacwag CS, et al. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem 2000;275:22245-54.
98. Christensen KL, Brennan JD, Aldridge CS, et al. Cell cycle regulation of the human Six1 homeoprotein is mediated by APC(Cdh1). Oncogene 2007;26:3406-14.
99. Jones AM, Mitter R, Poulsom R, et al. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol 2008;216:408-17.
100. McCoy EL, Iwanaga R, Jedlicka P, et al. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest 2009;119:2663-77.
101. Micalizzi DS, Christensen KL, Jedlicka P, et al. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest 2009;119:2678-90.
102. Radisky DC. Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis. J Clin Invest 2009;119:2528-31.
103. Muller-Tidow C, Ji P, Diederichs S, et al. The cyclin A1-CDK2 complex regulates DNA double-strand break repair. Mol Cell Biol 2004;24:8917-28.
104. Wegiel B, Bjartell A, Ekberg J, et al. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. Oncogene 2005;24:6385-93.
105. Rivera A, Mavila A, Bayless KJ, et al. Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells. Cell Mol Life Sci 2006;63:1425-39.
106. Coletta RD, Jedlicka P, Gutierrez-Hartmann A, et al. Transcriptional control of the cell cycle in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2004;9:39-53.
107. Yu Y, Davicioni E, Triche TJ, et al. The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res 2006;66:1982-9.
108. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
109. Jelic S, Sotiropoulos GC, Grp EGW. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21:v59-v64.
110. Thomas LR, Henson A, Reed JC, et al. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. J Biol Chem 2004;279:32780-5.
111. Thomas LR, Johnson RL, Reed JC, et al. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation. J Biol Chem 2004;279:52479-86.
112. Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 2005;23:9394-407.
113. Lee MY, Shen MR. Epithelial-mesenchymal transition in cervical carcinoma. Am J Transl Res 2012;4:1-13.
114. Farabaugh SM, Micalizzi DS, Jedlicka P, et al. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-beta signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 2012;31:552-62.
115. Li Z, Tian T, Lv F, et al. Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One 2013;8:e59203.
116. Kochhar A, Fischer SM, Kimberling WJ, et al. Branchio-oto-renal syndrome. Am J Med Genet A 2007;143A:1671-8.
117. Hoskins BE, Cramer CH, Silvius D, et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007;80:800-4.
118. Abdelhak S, Kalatzis V, Heilig R, et al. A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997;15:157-64.
119. Chang EH, Menezes M, Meyer NC, et al. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat 2004;23:582-9.
120. Kochhar A, Orten DJ, Sorensen JL, et al. SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR. Hum Mutat 2008;29:565.
121. Patrick AN, Schiemann BJ, Yang K, et al. Biochemical and Functional Characterization of Six SIX1 Branchio-oto-renal Syndrome Mutations. J Biol Chem 2009;284:20781-90.
122. Patrick AN, Cabrera JH, Smith AL, et al. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome. Nat Struct Mol Biol 2013;20:447-53.
123. Delgado-Olguin P, Huang Y, Li X, et al. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat Genet 2012;44:343-7.
124. Lee SH, Kim J, Ryu JY, et al. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy. J Mol Cell Cardiol 2012;52:718-26.
125. Schonberger J, Wang L, Shin JT, et al. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet 2005;37:418-22.
126. Mimae T, Okada M, Hagiyama M, et al. Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res 2012;18:945-55.
127. Wang QF, Wu G, Mi S, et al. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood 2011;117:6895-905.
128. Boucher CA, Carey N, Edwards YH, et al. Cloning of the human SIX1 gene and its assignment to chromosome 14. Genomics 1996;33:140-2.
129. Wu W, Ren Z, Wang Y, et al. Molecular characterization, expression patterns and polymorphism analysis of porcine Six1 gene. Mol Biol Rep 2011;38:2619-32.
130. Niro C, Demignon J, Vincent S, et al. Six1 and Six4 gene expression is necessary to activate the fast-type muscle gene program in the mouse primary myotome. Dev Biol 2010;338:168-82.
131. Jeong Y, Oh S. Identification of an evolutionarily conserved, functional noncoding element regulated by Six1 homeoprotein. Genes Genet Syst 2010;85:233-40.
132. Liu Y, Nandi S, Martel A, et al. Discovery, optimization and validation of an optimal DNA-binding sequence for the Six1 homeodomain transcription factor. Nucleic Acids Res 2012;40:8227-39.
133. Gianakopoulos PJ, Mehta V, Voronova A, et al. MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells. J Biol Chem 2011;286:2517-25.
134. Sato S, Ikeda K, Shioi G, et al. Regulation of Six1 expression by evolutionarily conserved enhancers in tetrapods. Dev Biol 2012;368:95-108.
135. Wu W, Ren Z, Liu H, et al. Core promoter analysis of porcine Six1 gene and its regulation of the promoter activity by CpG methylation. Gene 2013;529:238-44.
136. Heanue TA, Reshef R, Davis RJ, et al. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev 1999;13:3231-43.
137. Imam JS, Buddavarapu K, Lee-Chang JS, et al. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 2010;29:4971-9.
138. Vassilev LT, Vu BT, Graves B, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004;303:844-8.
139. Tse C, Shoemaker AR, Adickes J, et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 2008;68:3421-8.